Novel (−)-goniofufurone mimics: synthesis, antiproliferative activity and SAR analysis

Bojana Srećo Zelenović, Sladjana Kekezović, Mirjana Popsavin, Vesna Kojić, Goran Benedeković, Velimir Popsavin


Divergent synthesis of novel (−)-goniofufurone mimics with an alkoxymethyl group as the side chain have been accomplished from d-glucose in nine synthetic steps and in overall yields 6.7– 8.7%. Their in vitro antiproliferative activity was evaluated against eight human tumour cell lines as well as a single normal cell line. All analogues demonstrated powerful to good antiproliferative effects toward all malignant cell lines under evaluation. Against HL-60 cell line, all mimics showed increased activities being 27- to 1604-fold more potent than the lead compound, (−)-goniofufurone. Remarkably, the majority of synthesized analogues displayed higher or similar activity as commercial antitumour agent doxorubicin (DOX) against A549 cell line. The most potent compound exhibited 196-fold stronger cytotoxicity than DOX, in the culture of this cell line.


D-glucose; antitumour agents; goniofufurone mimics; cytotoxic lactones, structure-activity relationships

Full Text:

PDF (2,641 kB)


X. P. Fang, J. E. Anderson, C. J. Chang, P. E. Fanwick, J. L. McLaughlin, J. Chem. Soc. Perkin.Trans. 1 (1990) 1655 (

T. K. M. Shing, H. C. Tsui, Z. H. Zhou, Tetrahedron, 48 (1992) 8659 (

T. Gracza, V. Jäger, Synlett, 3 (1992) 191 (

M. Mondon, J.-P. Gesson, Curr. Org. Synth. 3 (2006) 41 (

G. Zhao, B. Wu, X. Y. Wu, Y. Z. Zhang, Mini-Rev. Org. Chem. 2 (2005) 333 (

L. Hernandez-Garcia, L. Quintero, H. Hopfl, M. Sosa, F. Sartillo-Piscil, Tetrahedron, 65 (2009) 139 (

K. R. Prasad, S. L. Gholap, J Org. Chem. 73 (2008) 2 (

P. Kapitan, T. Gracza, Tetrahedron: Asymmetry 19 (2008) 38 (

K. R. Prasad, M. G. Dhaware, Synthesis 23 (2007) 3697 (

V. K. Yadav, D. Agrawal, Chem. Commun. 48 (2007) 5232 (

C. Sartillo-Melendez, S. Cruz-Gregorio, L. Quintero, F Sartillo-Piscil, Lett. Org. Chem. 3 (2006) 504 ( )

M. D. Mihovilovic, D. A. Bianchi, F. Rudroff, Chem. Commun. 37 (2006) 3214 (

R. Fernández de la Pradilla, J. Fernández, A. Viso, J. Fernández, A. Gómez, Heterocycles 68 (2006) 1579 (

P. Ruiz, J. Murga, M. Carda, J. A. Marco, J. Org. Chem. 70 (2005) 713 (

A. de Fatima, L. V. Modolo, L.S. Conegero, R. A. Pilli, C.V. Ferreira, L. K. Kohn, J. E. de Carvalho, Curr. Med. Chem. 13 (2006) 3371 (

H.B. Mereyala, M. Joe, Curr. Med. Chem. Anti-Cancer Agents, 1 (2001) 293 (

Y.-L. Su, C.-S. Yang, S.-J. Teng, G. Zhao, Y. Ding, Tetrahedron, 57 (2001) 2147 ( )

T. Gracza, V. Jäger, Synthesis (1994) 1359 ( )

V. Popsavin, G. Benedeković, B. Srećo, J. Francuz, M. Popsavin, V. Kojić, G. Bogdanović, V. Divjaković, Tetrahedron, 65 (2009) 10596 (

V. Popsavin, G. Benedeković, B. Srećo, M. Popsavin, J. Francuz, V. Kojić, G. Bogdanović, Org. Lett. 9 (2007) 4235 (

B. Srećo, G. Benedeković, M. Popsavin, P. Hadžić, V. Kojić, G. Bogdanović, V. Divjaković, V. Popsavin, Tetrahedron, 67 (2011) 9358 (

V. Popsavin, B. Srećo, G. Benedeković, M. Popsavin, J. Francuz, V. Kojić, G. Bogdanović, Bioorg. Med. Chem. Lett. 18 (2008) 5182 (

T. Gracza, T. Hasenöhrl, U. Stahl, V. Jäger, Synthesis 1991 (1991) 1108 (

K. Bock, I. Lundt, C. Pedersen, Carbohydr. Res. 179 (1988) 87 (

D. A. Scudiero, R. H. Shoemaker, K. D. Paull, A. Monks, S. Tierney, T. H. Nofziger, M. J. Currens, D. Seniff, M. R. Boyd, Cancer. Res. 48 (1988) 4827 (


Copyright (c) 2019 Journal of the Serbian Chemical Society

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

IMPACT FACTOR 0.828 (140 of 172 journals)
5 Year Impact Factor 0.917 (140 of 172 journals)